T-1101

N/A

Report date: 2025/09/25 17:32:35
NME

Base Information

Drug NameT-1101
Drug Alias Name9jTosylateT-1101TAI-95
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitosis inhibitorsSerine/threonine-protein kinase NEK2 inhibitors
TargetsSerine/threonine-protein kinase NEK2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaivex Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesTaivex Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A